Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

Rouslan Kotchetkov, David Susman, Divaya Bhutani, Kaspar Broch, Angela Dispenzieri, Francis K. Buadi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalInternational Journal of Cancer
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this